A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Lilly's retatrutide shows remarkable weight loss in trials but raises concerns with side effects possibly linked to the drug like nausea and kidney stones. Read more here.

In ongoing trials of Eli Lilly’s (LLY) next-generation obesity drug, several trial participants are losing too much weight, STAT’s Elaine Chen ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

The Week is part of Future US Inc, an international media group and leading digital publisher. Visit our corporate site.